Zur Kurzanzeige

2023-04-20Berichte und sonstige Texte DOI: 10.25646/11228
Application of the Euroimmun Anti-SARS-CoV-2-NCP (IgG) and Anti-SARS-CoV-2-QuantiVac-ELISA (IgG) antibody tests to dried blood spots
dc.contributor.authorRobert Koch-Institut
dc.date.accessioned2023-04-20T09:29:47Z
dc.date.available2023-04-20T09:29:47Z
dc.date.issued2023-04-20none
dc.identifier.urihttp://edoc.rki.de/176904/10956
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleApplication of the Euroimmun Anti-SARS-CoV-2-NCP (IgG) and Anti-SARS-CoV-2-QuantiVac-ELISA (IgG) antibody tests to dried blood spotsnone
dc.typereport
dc.identifier.urnurn:nbn:de:0257-176904/10956-7
dc.identifier.doi10.25646/11228
local.edoc.pages6none
local.edoc.type-nameBerichte und sonstige Texte

Zur Kurzanzeige